| Nov 17 |
CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 15 |
CASI Pharmaceuticals reports Q3 results
|
| Nov 15 |
CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
|
| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 13 |
CASI Pharmaceuticals Q3 Earnings Preview
|
| Oct 24 |
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
|
| Sep 26 |
CASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past week
|
| Sep 4 |
CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE
|
| Jul 8 |
CASI Pharmaceuticals appoints Daniel Lang, MD as CFO
|
| Jul 8 |
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
|
